If You Invested in UMeWorld Limited (UMEWF)
See the UMEWF overviewWhat $1,000 or $10,000 in UMEWF Was Worth at Its Last Close
Real historical value by amount invested and how long before the last close| If you invested | 1 year before | 5 years before | 10 years before | Since May 21, 2025 |
|---|---|---|---|---|
| $1,000 | — | — | — | $1,333 +33% |
| $10,000 | — | — | — | $13,333 +33% |
Based on real historical closing prices adjusted for stock splits, without dividends, through the latest market close. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results. We start UMEWF on May 21, 2025 because the prices we hold from before that date cannot be compared with the later ones, and a return measured across the two would be wrong.
Custom Calculation
Choose your own date and amount for UMEWF$1,000 Investment Over Time
UMEWF vs S&P 500Year-by-Year Returns
UMEWF annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2025May 21 to Nov 17 | $0.27 | $0.36 | +33.3% | +33.3% |
About UMeWorld Limited
Consumer Defensive · OTC
UMeWorld Limited (OTC: UMEWF) is a Delaware-based company that focuses on functional nutrition, wellness technologies, and renewable energy applications built on enzymatic processing. According to recent corporate updates, the company operates through a dual platform: its DAGola-branded functional cooking oils and related wellness offerings, and an enzymatic biofuel platform targeting waste-based biodiesel and Sustainable Aviation Fuel (SAF) opportunities. UMeWorld’s shares trade on the OTC Markets under the symbol UMEWF, and operations are centered in Miami, Florida, with Asia-Pacific activities being established in Malaysia.
Business Model and Core Platforms
UMeWorld describes its strategy as a “one technology, two markets” approach. A proprietary enzymatic process underpins both its DAGola™ functional cooking oils and its enzymatic biofuels. In nutrition, the technology is used to produce diacylglycerol (DAG) oils formulated to contain significantly fewer triglycerides than conventional oils and to support improved lipid metabolism. In energy, the same enzymatic know-how is applied to convert low-cost, waste-based feedstocks into low-carbon biodiesel and to enable pathways toward SAF.
On the nutrition side, UMeWorld has built DAGola into its flagship consumer brand. Corporate disclosures describe DAGola as a science-backed cooking oil range with up to 50–80% fewer triglycerides than traditional oils, clinically validated in multiple human trials to support heart health, improve lipid metabolism, and help address metabolic syndrome. The company positions DAGola products for health-conscious consumers, athletes, and individuals focused on weight management and metabolic wellness.
DAGola Functional Cooking Oils and Product Innovation
UMeWorld reports that DAGola oils are produced using a proprietary enzymatic technology that increases DAG content relative to typical edible oils. Company communications state that DAGola oils have been evaluated in clinical studies, including work published in the Journal of Lipid Research and a separate study in overweight adults with elevated blood glucose. These studies reported reductions in triglycerides, uric acid, cholesterol, and body weight under controlled dietary conditions when DAG oil was used as the primary cooking fat.
The DAGola line has expanded into several blends tailored to different culinary and health use cases. Disclosed formulations include:
- DAGola Premium Blend – described as a versatile everyday oil with fewer triglycerides than traditional oils, enriched with vitamin E and omega-3 fatty acids, intended for active individuals and families.
- DAGola Vitality Blend – combining organic MCT oil, Olive DAG oil, and extra virgin olive oil (EVOO), with a specified DAG content and a focus on sustained energy, recovery, and performance.
- DAGola Gourmet Blend – a blend of EVOO and Olive DAG oil aimed at culinary enthusiasts, with a stated reduction in triglycerides compared to conventional oils.
- DAGola Master Chef Blend – combining avocado oil with Olive DAG oil, designed for high-performance kitchens and high-heat applications while offering fewer triglycerides than conventional oils.
UMeWorld reports that DAGola oils are bottled in the United States at a contract manufacturing facility in California, with pilot bottling runs completed for several blends. The company highlights a multi-channel go-to-market strategy that includes direct-to-consumer e-commerce, marketplace distribution, and supplying DAG oil as an ingredient to food manufacturers and private label customers.
Wellness Ecosystem: Supplements and AI-Powered App
Beyond cooking oils, UMeWorld has outlined its evolution into a full-spectrum wellness brand. Company announcements describe an expanded portfolio that includes:
- Cellugizer™ sports nutrition – a supplement line featuring products such as high-protein whey isolate, micronized creatine, and amino acid formulations with electrolytes, aimed at athletes and fitness enthusiasts.
- WellGenix™ – an AI-powered lifestyle app concept designed to provide personalized meal planning, workout optimization, and wellness tracking, with integration to DAGola and Cellugizer products.
UMeWorld presents this wellness ecosystem as a personalized, AI-supported approach to health that targets diverse consumer groups, including athletes, individuals focused on weight management, and broader health-conscious audiences. The company emphasizes a goal of delivering science-backed, customized solutions that address metabolic disorders, cardiovascular disease, obesity, and related conditions through everyday nutrition and lifestyle tools.
Enzymatic Biofuel and SAF Platform
In parallel with its nutrition and wellness activities, UMeWorld is advancing an enzymatic biofuel platform. Corporate updates describe plans for a biofuel pilot and industrial facilities in Malaysia that will process waste-based feedstocks such as palm oil mill effluent (POME), used cooking oil, and animal fats. The company states that its enzymatic process is designed to convert these inputs into sustainable biodiesel and to create intermediates suitable for SAF production.
UMeWorld has outlined a Malaysia-based facility with a planned annual capacity and has reported engagement with an international biofuel engineering group for process design, plant engineering, and project management. It has also identified a general contractor with industrial energy and biofuel experience and is evaluating Malaysian sites based on feedstock availability, logistics, utilities, permitting, and development timelines. The company has indicated an intention to establish a wholly owned subsidiary in Malaysia to operate the pilot facility.
According to company statements, the biofuel platform is engineered to align with EU ReFuelEU Aviation carbon-intensity thresholds, with the goal of positioning its output for eligibility under EU sustainability frameworks. UMeWorld also notes that certification in EU and U.S. markets is a key objective for its enzymatic biofuel, as this would support access to premium markets and potential carbon credit opportunities.
Geographic Footprint and Operations
UMeWorld reports that its operational activities are centered in Miami, Florida, with Asia-Pacific operations being established in Malaysia to support regional management, manufacturing coordination, and growth initiatives. Historically domiciled in the British Virgin Islands, the company has undertaken a statutory merger under which UMeWorld Inc., a Delaware corporation, became the surviving legal entity. Corporate disclosures state that operations are conducted through this Delaware entity, while certain public market references continue to use the name UMeWorld Limited (OTC: UMEWF) pending regulatory processes.
Capital Markets and Governance
UMeWorld has communicated a focus on capital markets readiness. The company has completed a redomiciliation to Delaware through a statutory merger and has engaged investment banking advisors to support a potential uplisting to the NYSE American or Nasdaq, subject to regulatory approvals and market conditions. It highlights this structure as supporting a U.S. reporting framework and aligning with institutional investors focused on environmental, social, and governance (ESG) and energy-transition themes.
An 8-K filing dated January 5, 2026, reports a change in the company’s independent registered public accounting firm due to required audit engagement partner rotation under Public Company Accounting Oversight Board independence rules. The filing notes that the former auditor’s reports for the referenced fiscal years did not contain adverse opinions or disclaimers and that there were no disagreements on accounting principles, financial statement disclosure, or auditing scope or procedure during the relevant periods.
Research, Clinical Validation, and Product Development
UMeWorld emphasizes scientific validation as a core element of its functional nutrition strategy. Company communications reference multiple clinical studies of DAG oil, including:
- A study in overweight adults with elevated blood glucose, in which exclusive use of DAG oil in home cooking was associated with reductions in uric acid, total cholesterol, LDL-C, triglycerides, body weight, and BMI over one to two months.
- A study published in the Journal of Lipid Research focusing on athletes with hyperuricemia, where DAGola oil consumption was associated with improved blood lipid profiles, reduced uric acid, lower triglycerides, reduced oxidative stress, and enhanced metabolic processing of waste products.
To support ongoing innovation, UMeWorld has established a Product Innovation & Development Center and appointed a Chief Scientist with experience in enzymatic science and commercial food innovation. The center’s stated focus is to translate advanced enzymatic research into market-ready functional foods that address metabolic disorders, cardiovascular disease, and obesity.
Strategic Focus and Market Positioning
Across its disclosures, UMeWorld positions itself at the intersection of functional nutrition, personalized wellness, and renewable energy. The company’s strategy highlights:
- Use of enzymatic processing to create DAG-rich cooking oils with reduced triglycerides and clinically supported metabolic benefits.
- Expansion of DAGola as both a branded consumer product line and a B2B ingredient for food manufacturers and private label programs.
- Development of AI-enabled wellness tools and supplement lines to build a broader health and performance ecosystem.
- Application of the same enzymatic technology to waste-based biodiesel and SAF-oriented feedstock processing, with a focus on regulatory alignment and certification.
UMeWorld’s public communications frame this combined approach as a way to address large public health challenges linked to diet and metabolic disease, while also contributing to lower-carbon energy solutions through biofuel and SAF-related projects.
Similar Stocks
See how related companies performed
Frequently Asked Questions
UMeWorld Limited investment returns
How much was $1,000 invested in UMeWorld Limited worth at its last close?
Limited historical data is available for UMEWF. The prices we can compare start on 2025-05-21.
Has UMeWorld Limited outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare UMEWF performance over available time periods.
For informational and educational purposes only, not investment advice.